A man was reinfected with coronavirus – what does this mean for immunity?
There is still much that is unknown about Covid-19, but a few possible explanations can be given for what happened in this case
A 33-year old man was found to have a second SARS-CoV-2 infection about 4½ months after he was diagnosed with his first, from which he had recovered. The man, who showed no symptoms, was diagnosed when he returned to Hong Kong after a trip to Spain.
I am a virologist with expertise in coronaviruses and enteroviruses, and I’ve been curious about reinfections since the beginning of the pandemic. Because people infected with SARS-CoV-2 can often test positive for the virus for weeks and even months – probably because of the sensitivity of the test and due to leftover RNA fragments – the only way to really answer the question of reinfection is by sequencing the viral genome at the time of each infection and looking for differences in the genetic code.
There is no published peer-review report on this man, only a press release from the University of Hong Kong, though reports say the work will be published in the journal Clinical Infectious Diseases.
So here I address some questions raised by those reports.
Why wasn’t the man immune to reinfection?
Immunity to endemic coronaviruses – those that cause symptoms of the common cold – is relatively short-lived, with reinfections occurring even within the same season. So it isn’t completely surprising that reinfection with SARS-CoV-2, the virus that causes Covid-19, might be possible.
Immunity is complex and involves multiple mechanisms in the body. That includes the generation of antibodies through what’s known as the adaptive immune response and through the actions of T-cells, which can help to educate the immune system and to specifically eliminate virus-infected cells.
However, researchers around the world are still learning about immunity to this virus and so can’t say for sure, based on this one case, whether reinfection will be a cause for broad concern.
How different is the second strain that infected the Hong Kong man?
“Strain” has a particular definition when referring to viruses. Often a different “strain” is a virus that behaves differently in some way. The coronavirus that infected this man in Europe is likely not a new strain.
A Stat News article reports that the genetic make up of the sequenced virus from the patient’s second infection had 24 nucleotides – the building blocks of the virus’s RNA genome – that differed from the SARS-CoV-2 isolate that infected him the first time.
SARS-CoV-2 has a genome that is made up of about 30,000 nucleotides, so the virus from the man’s second infection was roughly 0.08% different from the original in the genome sequence.
That shows that the virus that caused the second infection was new; not a recurrence of the first virus.
The man was asymptomatic – what does that mean?
The man wasn’t suffering any of the hallmark Covid-19 symptoms, which might mean he had some degree of protective immunity to the second infection because he didn’t seem sick. But this is difficult to prove.
I see three possible explanations.
The first is that the immunity he gained from the first infection protected him and allowed for a mild second infection.
The second possibility is that the infection was mild because he was presymptomatic and that he went on to develop symptoms in the coming days.
Finally, sometimes infections with SARS-CoV-2 are asymptomatic. At the moment it is difficult to determine whether this was due to the differences in the virus or in the host.
So what can we say about reinfection based on this one case?
Only that it seems to be possible after enough time has elapsed. We do not know how likely it is to occur or how or often it can.
Should people who have recovered from Covid-19 still wear a mask?
As we are still learning about how humans develop immunity to SARS-CoV-2 after infection, my recommendation is for continued masking, hand hygiene and distancing practices, even after recovery from Covid-19, to protect against the potential for reinfection.
*Freeman is a Paediatric Infectious Diseases Fellow at the University of Pittsburgh. This article was first published by The Conversation Africa
Would you like to comment on this article or view other readers' comments?
Register (it’s quick and free) or sign in now.
Please read our Comment Policy before commenting.